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Amifostine Aminothiols and Protection of Keratinocyte
Apoptosis and DNA Damage
To the Editor:
Amifostine (S-2±3-aminopropylaminoethyl phosphorothioic acid),
also known as WR-2721, is an aminothiol developed during the
1950s by the U.S. Army as a radio-protective agent (Murray, 1998).
Amifostine is dephosphorylated in vivo to the active metabolite
WR-1065, which enters cells by passive diffusion (Mitchell et al,
1995) and acts as a potent scavenger of free radicals and inhibitor of
DNA damage (Peters and van der Vijgh, 1995). Amifostine
protection of human leukemia cells against apoptosis induced by
ionizing radiation (IR) relates to its ability to prevent DNA strand
breaks (Warters et al, 1997). It effectively protects normal tissues
against the acute effects of IR and chemotherapy, and the drug is
widely used in cancer patients to increase the therapeutic bene®t of
radiotherapy and chemotherapy (Wasserman, 1999). Amifostine has
been particularly useful in reducing nephrotoxicity associated with
cisplatin administration (Markman, 1998) and radiation-induced
xerostomia in patients with squamous cell carcinoma of the head
and neck (Brizel et al, 2000). In addition, amifostine in some cases
has demonstrated anti-proliferative effects (Rubin et al, 1996) and
anti-tumor effects (Grdina et al 2002), suggesting its potential as a
chemopreventive as well as chemoprotective agent.
To the best of our knowledge, there are no studies
examining direct effects of these aminothiols on keratinocytes
and whether they can block keratinocyte apoptosis induced by
IR. In addition, their potential as protective agents against
ultraviolet (UV) B radiation, the primary carcinogen in sunlight
and etiologic agent for nonmelanoma skin cancers, has not been
formally addressed.
We thus examined the activity of both WR-1065 and amifostine
on the model keratinocyte cell line HaCat, which undergoes
apoptosis in response to both IR and UVB (Petit-Frere et al 2000).
First, HaCat cells (Grossman et al, 1999a) were preincubated for
15 min in Falcon 353001 dishes in the presence or absence of
freshly prepared WR-1065 (kindly provided by Dr Robert Schultz,
Drug Synthesis and Chemistry Branch, NCI, Bethesda, MD) or
amifostine (Ethyol, Alza Pharmaceuticals, Palo Alto, CA), and then
exposed to IR (7.5 Gy per min, J.L. Shepherd 137Cs source) as
described previously (Wilmore et al 2001). After replacing the
medium and culturing for 72 h, apoptosis was assessed by
propidium iodide staining of cellular DNA and ¯ow cytometry as
described previously (Grossman et al, 1999b). As shown in
Fig 1(A), IR induced a considerable level of apoptosis that was
signi®cantly reduced (p = 0.004, 0.01) in the presence of WR-
1065. The amifostine prodrug had a milder protective effect (not
shown), likely due to its decreased cell permeability compared with
WR-1065 (Calabro-Jones et al, 1985). Concentrations of either
drug in excess of 5 mM resulted in variable cytotoxicity, and
concentrations of 1 mM were less protective (not shown).
Next, we examined the ability of these aminothiols to protect
against UVB radiation. HaCat cells were preincubated in the
absence or presence of WR1065 or amifostine as above, and
then exposed to UVB (2 J per m2 per s, FS20T12-UVB bulbs,
National Biological Corporation, Twinsburg, OH) as described
previously (Grossman et al, 2001). After replacing the medium
and culturing for 24 h, apoptosis was assessed as above. UVB
induced a high level of apoptosis that was unaffected by WR-
1065 (Fig 1B) or amifostine (not shown). Failure to protect
against UVB-induced keratinocyte apoptosis suggested that these
aminothiols, in contrast to their ability to block IR-induced
DNA strand breaks (Warters et al, 1997), are unable to block
UVB-induced DNA damage, i.e., formation of UV photo-
products (Livneh et al, 1993). To con®rm this, HaCat cells
were preincubated in the presence or absence of amifostine and
WR1065 and then exposed to UVB as above. Cyclobutane
pyrimidine dimers (CPD) and 6±4 pyrimidine±pyrimidone (6±4)
photoproducts were detected using TDM-2 and 64M-2
monoclonal antibodies (Mori et al, 1991), respectively (kindly
provided by Dr Toshio Mori, Nara Medical University, Nara,
Japan). Genomic DNA was prepared as described previously
(Grossman et al, 2001) and spotted on Biotrace PVDF
membrane (ISC BioExpress, Kaysville, UT) for immunodot-
blot assay as described elsewhere (Adimoolam et al, 2001). As
shown in Fig 2, both CPD and 6±4 photoproducts were
readily detected immediately following higher levels of UVB
exposure, whereas none were seen in unirradiated cells. In
addition, UV photoproducts were not detected in cells exposed
to 10 or 20 Gy IR (not shown). Consistent with the apoptosis
responses above, in aminothiol-treated HaCat cells there was no
reduction in levels of either UV photoproduct compared with
cells not exposed to the drugs at the time points examined
(Fig 2).
We have thus shown that the aminothiol amifostine, and
particularly its active metabolite WR1065, can protect keratino-
cytes from apoptosis induced by IR. Reduced keratinocyte
apoptosis is the likely basis for the tissue-sparing effect seen in
patients with head and neck squamous cell carcinoma receiving
amifostine prior to radiotherapy. Our data suggest, however, that
these aminothiols are limited in their protective capacity for
keratinocytes to IR-induced DNA damage, and thus are likely not
to be useful as UV-protective agents in skin.
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Figure 2. Immunodetection of photoproducts induced by UVB.
HaCat cells were either untreated (rows 1 and 2) or preincubated with
5 mM amifostine (row 3) or WR-1065 (row 4) as indicated for 15 min,
prior to mock exposure (unirradiated; A1, A3, A4) or exposure to 100 J
per m2 (B1, C1, D1, E1, F1) or 400 J per m2 (B2, B3, B4, C2, C3, C4,
D2, D3, D4) UVB. Cells were then harvested immediately (column B)
or after incubating for 0.5 h (column C), 2 h (column D), 6 h (column
E) or 24 h (columns A, F) for preparation of genomic DNA. No DNA
was spotted at A2. For detection of CPD, 0.1 mg DNA was spotted at
each point. For detection of 6±4 photoproducts, 0.2 mg DNA was
spotted. Shown is a representative experiment of two performed. The
decreased level of CPD (F1) and 6±4 photoproducts (D2, D3, D4) after
prolonged incubation re¯ects DNA repair of photoproducts.
Figure 1. Apoptotic responses of HaCat keratinocytes and the
effect of WR-1065 preincubation. HaCat cells were either untreated
(s) or preincubated (d) with 5 mM WR-1065 for 15 min prior to
exposure to the indicated doses of (a) IR or (b) UVB. After 72 h (a) or
24 h (b), all cells were recovered and percent apoptosis was assessed by
propidium iodide staining and ¯ow cytometry. Apoptotic cells were
identi®ed as the sub-G1 (subdiploid) population and quantitated as a
percentage of the total cell population. Error bars indicate SEM from
four independent experiments performed. p-values determined by
unpaired t tests using Prism (Graphpad software, San Diego, CA):
*p = 0.004, **p = 0.01. p-values for unirradiated cells and UVB-
irradiated cells were not signi®cant (p > 0.05).
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